Related references
Note: Only part of the references are listed.Application of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signaling
Markku Varjosalo et al.
CELL (2008)
Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways
Jianping Xie et al.
VIROLOGY (2008)
Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus
Fuqu Yu et al.
PLOS PATHOGENS (2007)
Viral oncogene-induced DNA damage response is activated in Kaposi sarcoma tumorigenesis
Sonja Koopal et al.
PLOS PATHOGENS (2007)
Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency
Ke Lan et al.
VIROLOGY (2006)
KSHV encoded LANA upregulates Pim-1 and is a substrate for its kinase activity
Bharat G. Bajaj et al.
VIROLOGY (2006)
Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription
Fang Lu et al.
JOURNAL OF VIROLOGY (2006)
An essential role of ERK signalling in TPA-induced reactivation of Kaposi's sarcoma-associated herpesvirus
A Cohen et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats
SC Verma et al.
JOURNAL OF VIROLOGY (2006)
Structure and substrate specificity of the Pim-1 kinase
AN Bullock et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1
A Viejo-Borbolla et al.
JOURNAL OF VIROLOGY (2005)
The survival kinases Akt and Pim as potential pharmacological targets
R Amaravadi et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling
JJ Hoefnagel et al.
BLOOD (2005)
The serine/threonine kinase pim-1
M Bachmann et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Pim kinases are upregulated during Epstein-Barr virus infection and enhance EBNA2 activity
EM Rainio et al.
VIROLOGY (2005)
Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression
J Vieira et al.
VIROLOGY (2004)
Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors
H Mikkers et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis
A Grundhoff et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Viral load of human herpesvirus 8 (HHV-8) in the circulatory blood cells correlates with clinical progression in a patient with HHV-8-associated solid lymphoma with AIDS-associated Kaposi's sarcoma
J Song et al.
LEUKEMIA & LYMPHOMA (2004)
Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency
K Lan et al.
JOURNAL OF VIROLOGY (2004)
Disruption of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence
FC Ye et al.
JOURNAL OF VIROLOGY (2004)
The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jκ (CSL), the target of the Notch signaling pathway
YY Liang et al.
GENES & DEVELOPMENT (2002)
Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication
AC Garber et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases
DV Ablashi et al.
CLINICAL MICROBIOLOGY REVIEWS (2002)
Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR
FD Fakhari et al.
JOURNAL OF VIROLOGY (2002)
DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus
AC Garber et al.
JOURNAL OF VIROLOGY (2001)
Delineation of prognostic biomarkers in prostate cancer
SM Dhanasekaran et al.
NATURE (2001)
Transcription activation of polyadenylated nuclear RNA by Rta in human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus
MJ Song et al.
JOURNAL OF VIROLOGY (2001)
Potential cellular signatures of viral infections in human hematopoietic cells
J Mikovits et al.
DISEASE MARKERS (2001)
Auto-activation of the rta gene of human herpesvirus-8 Kaposi's sarcoma-associated herpesvirus
HY Deng et al.
JOURNAL OF GENERAL VIROLOGY (2000)
Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells
M Mercader et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Induction of human herpesvirus-8 gene expression by recombinant interferon gamma
DJ Blackbourn et al.
AIDS (2000)
Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lyric replication
J Chang et al.
VIROLOGY (2000)
Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases - Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease
C Parravicini et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
